Page last updated: 2024-12-07

sdds

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

SDDS: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID87190
CHEBI ID81723
MeSH IDM0044401

Synonyms (22)

Synonym
5-amino-2-[(4-aminophenyl)sulfonyl]benzenesulfonamide
metanilamide, 6-sulfanilyl-
sulfamoyldapsone
benzenesulfonamide, 5-amino-2-((4-aminophenyl)sulfonyl)-
brn 3435880
6-(p-anilinosulfonyl)metanilamide
2-sulfamonyl-4,4'-diaminophenylsulfone
2-sulfamonyl-4,4'-diaminodiphenyl-sulfone
sdds
5-amino-2-(4-aminophenyl)sulfonyl-benzenesulfonamide
6-sulfanilylmetanilamide
5-amino-2-(4-aminophenyl)sulfonylbenzenesulfonamide
17615-73-5
C18387
3-14-00-02271 (beilstein handbook reference)
2-sulfamoyl-4,4'-diaminodiphenyl sulfone
AKOS015898826
CHEBI:81723
DTXSID90170089
benzenesulfonamide, 5-amino-2-[(4-aminophenyl)sulfonyl]-
Q27155581
LXU2HPW98X

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Performance ratings, procedure details, and adverse events were collected."( Comparing the Safety and Efficacy of Two Commercially Available Single-Use Duodenoscopes: A Multicenter Study.
Abhyankar, PR; Andalib, I; Barber, J; Bareket, R; Bhenswala, P; Chalikonda, D; De Latour, R; Gabr, MM; Gaidhane, M; Gress, FG; Gurram, K; Kahaleh, M; Kowalski, TE; Kumar, A; Loren, DE; Nieto, J; Parker, K; Sarkar, A; Shahid, HM; Simon, A; Tyberg, A; Vareedayah, AA; Vazquez-Sequeiros, E; Zolotarevsky, E; Zolotarevsky, M, 2023
)
0.91
" None of the adverse events were related to the SDDs."( Comparing the Safety and Efficacy of Two Commercially Available Single-Use Duodenoscopes: A Multicenter Study.
Abhyankar, PR; Andalib, I; Barber, J; Bareket, R; Bhenswala, P; Chalikonda, D; De Latour, R; Gabr, MM; Gaidhane, M; Gress, FG; Gurram, K; Kahaleh, M; Kowalski, TE; Kumar, A; Loren, DE; Nieto, J; Parker, K; Sarkar, A; Shahid, HM; Simon, A; Tyberg, A; Vareedayah, AA; Vazquez-Sequeiros, E; Zolotarevsky, E; Zolotarevsky, M, 2023
)
1.17
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
benzenesAny benzenoid aromatic compound consisting of the benzene skeleton and its substituted derivatives.
sulfonamideAn amide of a sulfonic acid RS(=O)2NR'2.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (10.53)18.7374
1990's1 (5.26)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's16 (84.21)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 70.35

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index70.35 (24.57)
Research Supply Index3.04 (2.92)
Research Growth Index4.36 (4.65)
Search Engine Demand Index116.06 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (70.35)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (10.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other18 (90.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]